THYROID FUNCTION ABNORMALITIES IN PATIENTS WITH CHOLELITHIASIS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i2.50442Keywords:
Cholelithiasis, Thyroid function abnormalities, Hypothyroidism, ManagementAbstract
Objective: The objective of the study is to analyze the association between thyroid function abnormalities and cholelithiasis, focusing on the prevalence and types of thyroid dysfunctions in patients with gallstone disease compared to a healthy control group.
Methods: A comparative, hospital-based cross-sectional study was conducted in the department of general surgery at a tertiary care medical college. The study included 60 patients diagnosed with cholelithiasis (Group A) and 60 age-matched healthy individuals (Group B). Detailed history, physical examinations, ultrasound imaging, and thyroid function tests (TFTs) were performed. TFTs included measurements of free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone. Patients were categorized based on thyroid status into euthyroid, subclinical and clinical hypothyroidism, and hyperthyroidism. Statistical analysis was performed using SPSS version 21.0, with significance set at p<0.05.
Results: The study revealed a female preponderance in cholelithiasis cases (76.67% in Group A vs. 65.00% in Group B). The mean age and BMI were comparable between the groups. Thyroid function abnormalities were more prevalent in the cholelithiasis group (p=0.0251), with a higher incidence of hypothyroidism compared to the control group. Subclinical hypothyroidism was the most common thyroid dysfunction in cholelithiasis patients. Common complaints in the cholelithiasis group included anemia, menstrual irregularities, skin changes, and weakness.
Conclusion: The study demonstrates a significant association between cholelithiasis and thyroid function abnormalities, particularly hypothyroidism. The findings suggest the need for routine thyroid function evaluation in patients with cholelithiasis, which could influence management strategies and improve patient outcomes.
Downloads
References
Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol 2012;4:18-34. doi:10.4254/wjh.v4.i2.18
Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants 2005;15:329-38. doi:10.1615/ jlongtermeffmedimplants.v15.i3.90
Cremer A, Arvanitakis M. Diagnosis and management of bile stone disease and its complications. Minerva Gastroenterol Dietol 2016;62:103-29.
Millat B, Decker G, Fingerhut A. Imaging of cholelithiasis: What does the surgeon need?. Abdom Imaging 2001;26:3-6. doi:10.1007/ s002610000107
Lanzini A, Northfield TC. Pharmacological treatment of gallstones. Practical guidelines. Drugs 1994;47:458-70. doi:10.2165/00003495- 199447030-00006
Wirth J, Joshi AD, Song M, Lee DH, Tabung FK, Fung TT, et al. A healthy lifestyle pattern and the risk of symptomatic gallstone disease: Results from 2 prospective cohort studies. Am J Clin Nutr 2020;112:586-94. doi:10.1093/ajcn/nqaa154
Gurusamy KS, Davidson BR. Surgical treatment of gallstones. Gastroenterol Clin North Am 2010;39:229-44. doi:10.1016/j. gtc.2010.02.004
Mavromati M, Jornayvaz FR. Hypothyroidism-associated dyslipidemia: Potential molecular mechanisms leading to NAFLD. Int J Mol Sci 2021;22:12797. doi:10.3390/ijms222312797
Dawes LG, Greiner M, Joehl RJ. Altered gallbladder bile acidification with long-term total parenteral nutrition. J Surg Res 1999;81:21-6. doi:10.1006/jsre.1998.5492
Yago MD, González V, Serrano P, Calpena R, Martínez MA, Martínez- Victoria E, et al. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition 2005;21:339-47. doi:10.1016/j.nut.2004.06.028
Chen J, Zhou H, Jin H, Liu K. The causal effects of thyroid function and lipids on cholelithiasis: A Mendelian randomization analysis. Front Endocrinol (Lausanne) 2023;14:1166740. doi:10.3389/ fendo.2023.1166740
Dhar SC, Ansari S, Saha M, Ahmad MM, Rahman MT, Hasan M, et al. Gallstone disease in a rural Bangladeshi community. Indian J Gastroenterol 2001;20:223-6.
Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 2000;24 Suppl 2:S109-12. doi:10.1038/ sj.ijo.0801292
Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006;21:1737-43. doi:10.1111/j.1440-1746.2006.04381.x
Thijs C, Knipschild P, Van Engelshoven J. The prevalence of gallstone disease in a Dutch population. Scand J Gastroenterol 1990;25:155-60. doi:10.3109/00365529009107937
Ravi PC, Thugu TR, Singh J, Dasireddy RR, Kumar SA, Isaac NV, et al. gallstone disease and its correlation with thyroid disorders: A narrative review. Cureus 2023;15:e45116. doi:10.7759/cureus.45116
Kube I, Zwanziger D. Thyroid dysfunction and cholesterol gallstone disease. Exp Clin Endocrinol Diabetes 2020;128:455-61. doi:10.1055/a-1033-7273
Khan MA, Ahsan T, Rehman UL, Jabeen R, Farouq S. Subclinical hypothyroidism: Frequency, clinical presentations and treatment indications. Pak J Med Sci 2017;33:818-22. doi:10.12669/ pjms.334.12921
Yoo WS, Chung HK. Subclinical hypothyroidism: Prevalence, health impact, and treatment landscape. Endocrinol Metab (Seoul) 2021;36:500-13. doi:10.3803/EnM.2021.1066
Fatourechi V. Subclinical hypothyroidism: An update for primary care physicians. Mayo Clin Proc 2009;84:65-71. doi:10.4065/84.1.65
Published
How to Cite
Issue
Section
Copyright (c) 2023 Pooja D Kakade
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
